CA
ROIV icon

CoreCap Advisors’s Roivant Sciences ROIV Stock Holding History

CoreCap Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,400
Closed -$95.5K – 3045
2025
Q4 		$95.5K Hold
4,400
– – ﹤0.01% 1050
2025
Q3 		$66.6K Hold
4,400
– – ﹤0.01% 1195
2025
Q2 		$49.6K Sell
4,400
-2,000
-31% -$21.7K ﹤0.01% 1265
2025
Q1 		$64.6K Buy
6,400
+1,850
+41% +$20K ﹤0.01% 1065
2024
Q4 		$53.8K Buy
4,550
+150
+3% +$1.77K ﹤0.01% 1154
2024
Q3 		$50.8K Buy
+4,400
New +$50.1K ﹤0.01% 1173

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CoreCap Advisors's ROIV Position: Q1 2026 in Review

CoreCap Advisors sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 4,400 shares — an estimated $95.5K sold.

CoreCap Advisors first reported a position in ROIV in Q3 2024 and held it in 6 quarters. The position peaked at $95.5K in Q4 2025. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • CoreCap Advisors reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • CoreCap Advisors sold 4,400 Roivant Sciences shares in Q1 2026, an estimated $95.5K.
  • CoreCap Advisors first reported a position in Roivant Sciences in Q3 2024 and held it in 6 quarters.
  • CoreCap Advisors's Roivant Sciences position peaked at $95.5K in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on CoreCap Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.